Exact Sciences Corporation (EXAS): Consensus Estimates and Trading Data

In the past 52-week period, shares of Exact Sciences Corporation (NASDAQ:EXAS) have moved within the range of $13.05 to $57.95. On the stock’s most recent trading day, the company’s shares ended the regular session at $56.71, which is 2.14% lower than its 52-week high.

Exact Sciences Corporation (EXAS) has demonstrated a 20-day simple moving average (SMA) of 14.82%, and a 50-day SMA of 23.24%. This public company’s current market capitalization stands at $6.76 billion.

Analyzing Consensus Estimates, Sales Revenue and Net Income

When thinking about buying shares in a public company, it is useful to gauge the average enthusiasm level of Wall Street analysts for that specific stock. According to the latest data, the consensus recommendation for Exact Sciences Corporation (EXAS) is Outperform.

When it comes to quarterly financial results, publicly-traded companies usually post earnings and revenue figures that fall somewhat above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Exact Sciences Corporation (EXAS) delivered a 11.63% surprise with its net revenue. Sales reached $0.07 billion during the three-month period, compared to the average analyst estimate of $0.07 billion.

Meanwhile, during the same quarter Exact Sciences Corporation (EXAS) delivered a -22.74% earnings surprise. Net earnings for the quarter were posted at -$0.23 per share, whereas Wall Street had forecast -$0.30 per share.

Ownership at Exact Sciences Corporation (EXAS), According to Most Recent SEC Filings

Investors can gain useful insight on institutional ownership within a public company by taking a look at the organization’s most recent 13F filings. Exact Sciences Corporation (EXAS) has 0.12 billion shares outstanding currently, 87.55% of which belong to institutional investors. Those institutional holdings amount to $5.94 billion.

Additionally, according to the most recent 13F filing from Exact Sciences Corporation (EXAS), there were 61 new positions totaling 8,932,588 shares of the company’s stock. There were 22 sold out positions, on the other hand, totaling 2,359,405 shares.

Short, Medium and Long Term Indicators

By looking at a stock’s average trade volume – in the short, medium, and long terms – we can gain a better understanding of investor sentiment and trading activity. Exact Sciences Corporation (EXAS) has had a 20-day average volume of 1,855,455 shares, with an average of 100% of short term indicators pointed at Buy.

The stock’s 50-day average volume has been 1,663,918 shares, with an average of 100% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 1,785,995 shares with 100% of long-term indicators pointing to Buy.